| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.597 | 0.003 | 0.734 | DNA polymerase I inhibitor | 0.604 0.002 DBMET01152 0.586 0.003 DBMET01153 0.696 0.001 DBMET01154 0.724 0.001 DBMET01155 0.707 0.001 DBMET01156 0.734 0.001 DBMET01157 | DBMET01157 | |
| 0.486 | 0.012 | 0.987 | RNA-directed DNA polymerase inhibitor | 0.947 0.001 DBMET01152 0.91 0.001 DBMET01153 0.977 0 DBMET01154 0.983 0 DBMET01155 0.983 0 DBMET01156 0.987 0 DBMET01157 | DBMET01157 | |
| 0.488 | 0.014 | 0.992 | DNA synthesis inhibitor | 0.973 0.001 DBMET01152 0.938 0.001 DBMET01153 0.988 0.001 DBMET01154 0.991 0 DBMET01155 0.989 0.001 DBMET01156 0.992 0 DBMET01157 | DBMET01157 | |
| 0.394 | 0.003 | 0.394 | MAP kinase 3 inhibitor | 0.209 0.02 DBMET01152 0.145 0.076 DBMET01154 0.133 0.099 DBMET01155 | ||
| 0.433 | 0.048 | 0.433 | GABA C receptor rho-3 antagonist | |||
| 0.386 | 0.006 | 0.386 | Bronchodilator | |||
| 0.426 | 0.054 | 0.574 | Immunosuppressant | 0.574 0.017 DBMET01152 0.565 0.018 DBMET01153 0.521 0.028 DBMET01154 0.513 0.029 DBMET01155 0.52 0.028 DBMET01156 0.513 0.03 DBMET01157 | DBMET01152 | |
| 0.393 | 0.029 | 0.393 | Interleukin 2 agonist | 0.319 0.061 DBMET01152 0.295 0.077 DBMET01154 0.287 0.083 DBMET01155 0.271 0.097 DBMET01156 0.263 0.105 DBMET01157 | ||
| 0.367 | 0.032 | 0.367 | Tyrosine kinase inhibitor | |||
| 0.324 | 0.01 | 0.324 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.311 | 0.006 | 0.502 | Adenosine A1 receptor antagonist | 0.502 0.003 DBMET01152 0.308 0.006 DBMET01153 0.328 0.005 DBMET01154 0.288 0.007 DBMET01155 0.223 0.009 DBMET01156 0.192 0.012 DBMET01157 | DBMET01152 | |
| 0.31 | 0.033 | 0.31 | EphB2 antagonist | |||
| 0.282 | 0.006 | 0.311 | Adenosine A2 receptor antagonist | 0.311 0.005 DBMET01152 0.152 0.016 DBMET01153 0.215 0.009 DBMET01154 0.182 0.012 DBMET01155 0.07 0.04 DBMET01156 | DBMET01152 | |
| 0.29 | 0.016 | 0.29 | Glycogen synthase kinase-3 inhibitor | |||
| 0.287 | 0.015 | 0.287 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.28 | 0.009 | 0.28 | Xanthine oxidase inhibitor | |||
| 0.273 | 0.004 | 0.273 | Folate antagonist | 0.208 0.009 DBMET01152 0.208 0.009 DBMET01153 0.169 0.016 DBMET01154 0.163 0.018 DBMET01155 0.158 0.02 DBMET01156 0.152 0.022 DBMET01157 | ||
| 0.269 | 0.005 | 0.269 | Phosphodiesterase 7B inhibitor | |||
| 0.287 | 0.028 | 0.287 | Src kinase inhibitor | |||
| 0.262 | 0.007 | 0.621 | Alcohol dehydrogenase inhibitor | 0.591 0.002 DBMET01152 0.21 0.011 DBMET01153 0.621 0.002 DBMET01154 0.592 0.002 DBMET01155 0.425 0.004 DBMET01156 0.372 0.004 DBMET01157 | DBMET01154 | |
| 0.244 | 0.019 | 0.244 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.335 | 0.111 | 0.575 | Antibacterial | 0.575 0.023 DBMET01152 0.454 0.055 DBMET01153 0.555 0.027 DBMET01154 0.527 0.033 DBMET01155 0.548 0.029 DBMET01156 0.518 0.036 DBMET01157 | DBMET01152 | |
| 0.235 | 0.015 | 0.235 | GABA C receptor agonist | |||
| 0.245 | 0.026 | 0.245 | c-Src kinase inhibitor | |||
| 0.245 | 0.036 | 0.245 | Nitric-oxide synthase stimulant | |||
| 0.218 | 0.009 | 0.887 | Antimetabolite | 0.804 0.001 DBMET01152 0.518 0.002 DBMET01153 0.879 0.001 DBMET01154 0.886 0.001 DBMET01155 0.88 0.001 DBMET01156 0.887 0.001 DBMET01157 | DBMET01157 | |
| 0.262 | 0.062 | 0.262 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.195 | 0.001 | 0.195 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.03 0.003 DBMET01152 0.029 0.003 DBMET01153 0.028 0.003 DBMET01154 0.027 0.004 DBMET01155 0.03 0.003 DBMET01156 0.029 0.003 DBMET01157 | ||
| 0.262 | 0.078 | 0.262 | Aldehyde oxidase inhibitor | |||
| 0.195 | 0.012 | 0.195 | Janus tyrosine kinase 3 inhibitor | |||
| 0.341 | 0.161 | 0.341 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.247 | 0.073 | 0.247 | Dyrk kinase inhibitor | |||
| 0.278 | 0.104 | 0.278 | Angiogenesis inhibitor | |||
| 0.185 | 0.012 | 0.806 | NADH dehydrogenase inhibitor | 0.762 0.001 DBMET01152 0.729 0.001 DBMET01153 0.806 0.001 DBMET01154 0.792 0.001 DBMET01155 0.786 0.001 DBMET01156 0.771 0.001 DBMET01157 | DBMET01154 | |
| 0.185 | 0.012 | 0.617 | DNA repair enzyme inhibitor | 0.617 0.002 DBMET01152 0.565 0.002 DBMET01153 0.404 0.003 DBMET01154 0.363 0.004 DBMET01155 0.419 0.003 DBMET01156 0.375 0.004 DBMET01157 | DBMET01152 | |
| 0.224 | 0.053 | 0.224 | Peroxidase inhibitor | |||
| 0.182 | 0.012 | 0.182 | Adenosine A2a receptor antagonist | 0.171 0.013 DBMET01152 0.125 0.019 DBMET01153 0.117 0.021 DBMET01154 0.09 0.028 DBMET01155 | ||
| 0.201 | 0.034 | 0.201 | Cyclooxygenase 1 inhibitor | |||
| 0.242 | 0.077 | 0.242 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.201 | 0.04 | 0.201 | Lck kinase inhibitor | |||
| 0.194 | 0.048 | 0.194 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.236 | 0.09 | 0.503 | Interleukin agonist | 0.503 0.009 DBMET01152 0.31 0.043 DBMET01153 0.403 0.018 DBMET01154 0.37 0.024 DBMET01155 0.264 0.069 DBMET01156 0.236 0.089 DBMET01157 | DBMET01152 | |
| 0.157 | 0.013 | 0.157 | CDK1/cyclin B inhibitor | |||
| 0.155 | 0.012 | 0.155 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.145 | 0.009 | 0.824 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.74 0 DBMET01152 0.649 0.001 DBMET01153 0.805 0 DBMET01154 0.824 0 DBMET01155 0.771 0 DBMET01156 0.792 0 DBMET01157 | DBMET01155 | |
| 0.149 | 0.016 | 0.149 | CDK1/cyclin B1 inhibitor | |||
| 0.129 | 0.001 | 0.78 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.457 0 DBMET01152 0.246 0 DBMET01153 0.72 0 DBMET01154 0.78 0 DBMET01155 0.28 0 DBMET01156 0.301 0 DBMET01157 | DBMET01155 | |
| 0.198 | 0.075 | 0.198 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.136 | 0.014 | 0.136 | Alpha 2d adrenoreceptor antagonist | |||
| 0.124 | 0.004 | 0.465 | AICAR transformylase inhibitor | 0.465 0 DBMET01152 0.278 0.001 DBMET01153 0.319 0.001 DBMET01154 0.297 0.001 DBMET01155 0.203 0.002 DBMET01156 0.19 0.002 DBMET01157 | DBMET01152 | |
| 0.123 | 0.007 | 0.123 | Cyclin B1 inhibitor | |||
| 0.13 | 0.014 | 0.843 | Argininosuccinate synthase inhibitor | 0.764 0.001 DBMET01152 0.715 0.001 DBMET01153 0.825 0 DBMET01154 0.843 0 DBMET01155 0.824 0 DBMET01156 0.842 0 DBMET01157 | DBMET01155 | |
| 0.145 | 0.029 | 0.145 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.191 | 0.08 | 0.757 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.695 0.001 DBMET01152 0.645 0.002 DBMET01153 0.757 0.001 DBMET01154 0.728 0.001 DBMET01155 0.671 0.001 DBMET01156 0.66 0.001 DBMET01157 | DBMET01154 | |
| 0.114 | 0.007 | 0.114 | Cyclin B2 inhibitor | |||
| 0.171 | 0.065 | 0.171 | Polo-like kinase-3 inhibitor | |||
| 0.113 | 0.007 | 0.113 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.091 0.022 DBMET01152 0.072 0.056 DBMET01153 0.073 0.051 DBMET01154 0.068 0.066 DBMET01155 | ||
| 0.152 | 0.048 | 0.152 | Aurora-C kinase inhibitor | |||
| 0.123 | 0.022 | 0.876 | Glutamate dehydrogenase inhibitor | 0.833 0.001 DBMET01152 0.796 0.001 DBMET01153 0.867 0.001 DBMET01154 0.876 0.001 DBMET01155 0.77 0.001 DBMET01156 0.791 0.001 DBMET01157 | DBMET01155 | |
| 0.108 | 0.009 | 0.108 | Cyclin B inhibitor | |||
| 0.14 | 0.041 | 0.14 | Platelet activating factor beta antagonist | |||
| 0.13 | 0.032 | 0.13 | GABA C receptor rho-1 antagonist | |||
| 0.118 | 0.021 | 0.118 | Myeloperoxidase inhibitor | |||
| 0.116 | 0.019 | 0.116 | mTOR complex 2 inhibitor | |||
| 0.104 | 0.008 | 0.104 | Histamine agonist | |||
| 0.192 | 0.097 | 0.192 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.155 | 0.061 | 0.155 | Ribosomal protein S6 kinase inhibitor | |||
| 0.103 | 0.01 | 0.103 | MAP kinase kinase 7 inhibitor | |||
| 0.112 | 0.021 | 0.162 | Adenosine A3 receptor antagonist | 0.162 0.011 DBMET01152 0.152 0.012 DBMET01153 0.153 0.012 DBMET01154 0.153 0.012 DBMET01155 0.089 0.033 DBMET01156 0.089 0.033 DBMET01157 | DBMET01152 | |
| 0.169 | 0.081 | 0.169 | LIM domain kinase 1 inhibitor | |||
| 0.094 | 0.006 | 0.678 | Adenosine deaminase inhibitor | 0.533 0.001 DBMET01152 0.438 0.001 DBMET01153 0.678 0.001 DBMET01154 0.599 0.001 DBMET01155 0.655 0.001 DBMET01156 0.573 0.001 DBMET01157 | DBMET01154 | |
| 0.118 | 0.031 | 0.118 | mTOR complex 1 inhibitor | |||
| 0.094 | 0.007 | 0.928 | Thymidine kinase inhibitor | 0.778 0.001 DBMET01152 0.747 0.001 DBMET01153 0.876 0.001 DBMET01154 0.898 0.001 DBMET01155 0.906 0 DBMET01156 0.928 0 DBMET01157 | DBMET01157 | |
| 0.105 | 0.019 | 0.733 | Carbamoyl phosphate synthetase inhibitor | 0.679 0.001 DBMET01152 0.649 0.001 DBMET01153 0.72 0.001 DBMET01154 0.733 0 DBMET01155 0.628 0.001 DBMET01156 0.645 0.001 DBMET01157 | DBMET01155 | |
| 0.107 | 0.023 | 0.107 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.124 | 0.04 | 0.599 | Adenylate kinase inhibitor | 0.555 0.001 DBMET01152 0.54 0.001 DBMET01153 0.589 0.001 DBMET01154 0.599 0 DBMET01155 0.503 0.001 DBMET01156 0.516 0.001 DBMET01157 | DBMET01155 | |
| 0.128 | 0.045 | 0.128 | GABA C receptor antagonist | |||
| 0.088 | 0.013 | 0.088 | Factor IXa inhibitor | |||
| 0.081 | 0.007 | 0.081 | Histamine H2 receptor agonist | |||
| 0.079 | 0.008 | 0.245 | Thymidylate synthase inhibitor | 0.245 0.002 DBMET01152 0.166 0.003 DBMET01153 0.131 0.003 DBMET01154 0.115 0.004 DBMET01155 0.162 0.003 DBMET01156 0.141 0.003 DBMET01157 | DBMET01152 | |
| 0.078 | 0.007 | 0.078 | Histamine H3 receptor agonist | |||
| 0.13 | 0.059 | 0.715 | Adenylate cyclase inhibitor | 0.657 0.002 DBMET01152 0.674 0.002 DBMET01153 0.699 0.002 DBMET01154 0.713 0.001 DBMET01155 0.702 0.002 DBMET01156 0.715 0.001 DBMET01157 | DBMET01157 | |
| 0.121 | 0.051 | 0.121 | Nav1.4 sodium channel blocker | |||
| 0.072 | 0.004 | 0.072 | Histamine H4 receptor agonist | |||
| 0.072 | 0.006 | 0.222 | Purinergic P2Y2 antagonist | 0.175 0.002 DBMET01152 0.13 0.003 DBMET01153 0.211 0.001 DBMET01154 0.222 0.001 DBMET01155 0.193 0.002 DBMET01156 0.203 0.002 DBMET01157 | DBMET01155 | |
| 0.145 | 0.08 | 0.145 | GABA C receptor rho-2 antagonist | |||
| 0.088 | 0.023 | 0.088 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.097 | 0.033 | 0.826 | Phosphofructokinase-1 inhibitor | 0.723 0.001 DBMET01152 0.673 0.001 DBMET01153 0.802 0.001 DBMET01154 0.826 0.001 DBMET01155 0.643 0.001 DBMET01156 0.669 0.001 DBMET01157 | DBMET01155 | |
| 0.098 | 0.034 | 0.098 | Raf kinase inhibitor | |||
| 0.109 | 0.047 | 0.512 | DNA directed RNA polymerase inhibitor | 0.297 0.007 DBMET01152 0.21 0.012 DBMET01153 0.436 0.004 DBMET01154 0.494 0.004 DBMET01155 0.46 0.004 DBMET01156 0.512 0.004 DBMET01157 | DBMET01157 | |
| 0.128 | 0.068 | 0.128 | Cyclin-dependent kinase inhibitor | |||
| 0.083 | 0.024 | 0.083 | Carbonic anhydrase stimulant | |||
| 0.139 | 0.084 | 0.771 | Cytidine deaminase inhibitor | 0.641 0.004 DBMET01152 0.535 0.005 DBMET01153 0.741 0.003 DBMET01154 0.771 0.002 DBMET01155 0.739 0.003 DBMET01156 0.769 0.002 DBMET01157 | DBMET01155 | |
| 0.064 | 0.012 | 0.064 | Dopamine beta hydroxylase inhibitor | |||
| 0.095 | 0.043 | 0.095 | TIE-2 antagonist | |||
| 0.098 | 0.047 | 0.098 | Histamine N-methyltransferase inhibitor | |||
| 0.074 | 0.024 | 0.833 | Ornithine carbamoyltransferase inhibitor | 0.74 0.001 DBMET01152 0.76 0.001 DBMET01153 0.815 0.001 DBMET01154 0.833 0.001 DBMET01155 0.566 0.002 DBMET01156 0.622 0.002 DBMET01157 | DBMET01155 | |
| 0.095 | 0.045 | 0.095 | TIE antagonist | |||
| 0.064 | 0.016 | 0.064 | Alpha 1b adrenoreceptor agonist | |||
| 0.06 | 0.012 | 0.06 | Dihydropteroate synthase inhibitor | |||
| 0.107 | 0.059 | 0.107 | Check point kinase 2 inhibitor | |||
| 0.063 | 0.016 | 0.063 | Histamine H4 receptor antagonist | |||
| 0.137 | 0.092 | 0.137 | MAP kinase kinase 4 inhibitor | |||
| 0.101 | 0.056 | 0.101 | MAP kinase kinase 1 inhibitor | |||
| 0.11 | 0.066 | 0.11 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.111 | 0.068 | 0.111 | Protein kinase (CK2) alpha inhibitor | |||
| 0.072 | 0.03 | 0.072 | Xanthine dehydrogenase inhibitor | |||
| 0.082 | 0.04 | 0.082 | Protein kinase B beta inhibitor | |||
| 0.054 | 0.013 | 0.054 | Histamine H1 receptor agonist | |||
| 0.154 | 0.115 | 0.154 | I kappa B kinase epsilon inhibitor | |||
| 0.11 | 0.073 | 0.11 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.093 | 0.057 | 0.093 | CDK/cyclin complex inhibitor | |||
| 0.095 | 0.062 | 0.095 | CDK2/cyclin A inhibitor | |||
| 0.189 | 0.158 | 0.189 | MAP kinase kinase 3 inhibitor | |||
| 0.036 | 0.006 | 0.291 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.291 0.001 DBMET01152 0.272 0.001 DBMET01153 0.119 0.002 DBMET01154 0.091 0.002 DBMET01155 0.156 0.002 DBMET01156 0.127 0.002 DBMET01157 | DBMET01152 | |
| 0.048 | 0.018 | 0.048 | Alpha 1d adrenoreceptor agonist | |||
| 0.036 | 0.007 | 0.036 | Alpha 2d adrenoreceptor agonist | |||
| 0.075 | 0.046 | 0.075 | MAP3K7 inhibitor | |||
| 0.057 | 0.028 | 0.057 | Carbonic anhydrase II stimulant | |||
| 0.161 | 0.134 | 0.191 | Cyclic AMP phosphodiesterase inhibitor | 0.184 0.107 DBMET01152 0.191 0.101 DBMET01153 | DBMET01153 | |
| 0.119 | 0.092 | 0.119 | Histone deacetylase SIRT1 inhibitor | |||
| 0.06 | 0.033 | 0.327 | Acyl-CoA dehydrogenase inhibitor | 0.303 0.001 DBMET01152 0.297 0.001 DBMET01153 0.327 0.001 DBMET01154 0.319 0.001 DBMET01155 0.287 0.002 DBMET01156 0.278 0.002 DBMET01157 | DBMET01154 | |
| 0.167 | 0.141 | 0.671 | Immunostimulant | 0.67 0.01 DBMET01152 0.607 0.016 DBMET01153 0.671 0.01 DBMET01154 0.656 0.011 DBMET01155 0.66 0.011 DBMET01156 0.644 0.012 DBMET01157 | DBMET01154 | |
| 0.062 | 0.039 | 0.547 | Biliverdin reductase inhibitor | 0.526 0.001 DBMET01152 0.484 0.001 DBMET01153 0.547 0.001 DBMET01154 0.526 0.001 DBMET01155 0.39 0.002 DBMET01156 0.365 0.002 DBMET01157 | DBMET01154 | |
| 0.087 | 0.064 | 0.421 | Phosphodiesterase I inhibitor | 0.286 0.005 DBMET01152 0.153 0.017 DBMET01153 0.391 0.004 DBMET01154 0.421 0.003 DBMET01155 0.239 0.007 DBMET01156 0.267 0.005 DBMET01157 | DBMET01155 | |
| 0.046 | 0.024 | 0.046 | CDK5/p25 inhibitor | |||
| 0.052 | 0.031 | 0.052 | Adenosine A2b receptor antagonist | |||
| 0.023 | 0.003 | 0.436 | Purine nucleoside phosphorylase inhibitor | 0.079 0.001 DBMET01152 0.436 0.001 DBMET01153 0.133 0.001 DBMET01154 0.107 0.001 DBMET01155 0.038 0.002 DBMET01156 0.03 0.002 DBMET01157 | DBMET01153 | |
| 0.061 | 0.041 | 0.061 | Alpha 2 adrenoreceptor agonist | |||
| 0.025 | 0.006 | 0.025 | Alpha 2c adrenoreceptor agonist | |||
| 0.1 | 0.082 | 0.1 | Vascular endothelial growth factor antagonist | |||
| 0.038 | 0.021 | 0.56 | Phosphoglycerate kinase inhibitor | 0.523 0.001 DBMET01152 0.506 0.001 DBMET01153 0.549 0 DBMET01154 0.56 0 DBMET01155 0.477 0.001 DBMET01156 0.491 0.001 DBMET01157 | DBMET01155 | |
| 0.031 | 0.015 | 0.038 | Purinergic P2Y15 antagonist | 0.038 0.008 DBMET01152 0.033 0.012 DBMET01153 0.031 0.016 DBMET01154 0.028 0.021 DBMET01155 | DBMET01152 | |
| 0.152 | 0.136 | 0.152 | Growth factor agonist | |||
| 0.022 | 0.008 | 0.022 | Alpha 2b adrenoreceptor agonist | |||
| 0.06 | 0.047 | 0.06 | Phosphodiesterase VII inhibitor | |||
| 0.13 | 0.118 | 0.13 | CF transmembrane conductance regulator agonist | |||
| 0.221 | 0.211 | 0.813 | DNA directed DNA polymerase inhibitor | 0.393 0.118 DBMET01152 0.637 0.047 DBMET01154 0.704 0.034 DBMET01155 0.762 0.025 DBMET01156 0.813 0.017 DBMET01157 | DBMET01157 | |
| 0.086 | 0.076 | 0.086 | Protein kinase (CK2) inhibitor | |||
| 0.013 | 0.003 | 0.013 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.006 DBMET01152 | ||
| 0.019 | 0.01 | 0.019 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.026 | 0.018 | 0.087 | Thymidine phosphorylase inhibitor | 0.087 0.003 DBMET01152 0.047 0.005 DBMET01153 0.05 0.005 DBMET01154 0.043 0.006 DBMET01155 0.053 0.004 DBMET01156 0.045 0.005 DBMET01157 | DBMET01152 | |
| 0.021 | 0.013 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.087 | 0.081 | 0.087 | Electrolyte absorption antagonist | |||
| 0.041 | 0.036 | 0.041 | Dihydrofolate reductase inhibitor | |||
| 0.016 | 0.011 | 0.016 | CDK2/cyclin A3 inhibitor | |||
| 0.062 | 0.057 | 0.062 | Syk tyrosine kinase inhibitor | |||
| 0.032 | 0.027 | 0.863 | Fumarate hydratase inhibitor | 0.792 0.001 DBMET01152 0.742 0.001 DBMET01153 0.848 0.001 DBMET01154 0.863 0.001 DBMET01155 0.674 0.001 DBMET01156 0.719 0.001 DBMET01157 | DBMET01155 | |
| 0.085 | 0.081 | 0.085 | MAP kinase kinase kinase inhibitor | |||
| 0.064 | 0.06 | 0.064 | Exportin-1 inhibitor | |||
| 0.074 | 0.07 | 0.074 | AXL receptor tyrosine kinase inhibitor | |||
| 0.062 | 0.058 | 0.062 | Protein kinase B alpha inhibitor | |||
| 0.021 | 0.017 | 0.021 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.083 | 0.08 | 0.083 | Ephrin antagonist | |||
| 0.088 | 0.085 | 0.088 | Ferrochelatase inhibitor | |||
| 0.018 | 0.018 | 0.765 | Adenosine kinase inhibitor | 0.555 0.001 DBMET01152 0.328 0.001 DBMET01153 0.716 0.001 DBMET01154 0.765 0.001 DBMET01155 0.638 0.001 DBMET01156 0.678 0.001 DBMET01157 | DBMET01155 | |
| 0.008 | 0.011 | 0.282 | Purinergic P2Y2 agonist | 0.118 0 DBMET01152 0.072 0 DBMET01153 0.237 0 DBMET01154 0.282 0 DBMET01155 0.169 0 DBMET01156 0.215 0 DBMET01157 | DBMET01155 | |
| 0.013 | 0.017 | 0.189 | Purinergic P2Y1 agonist | 0.158 0.001 DBMET01152 0.189 0 DBMET01153 0.178 0 DBMET01154 0.185 0 DBMET01155 0.172 0 DBMET01156 0.178 0 DBMET01157 | DBMET01153 | |
| 0.011 | 0.016 | 0.044 | Adenosine A2a receptor agonist | 0.044 0.003 DBMET01152 0.042 0.003 DBMET01153 0.03 0.005 DBMET01154 0.026 0.006 DBMET01155 | DBMET01152 | |
| 0.013 | 0.018 | 0.043 | Adenosine A2 receptor agonist | 0.043 0.004 DBMET01152 0.035 0.005 DBMET01153 0.023 0.007 DBMET01154 0.02 0.008 DBMET01155 | DBMET01152 | |
| 0.014 | 0.021 | 0.062 | Adenosine A3 receptor agonist | 0.062 0.004 DBMET01152 0.056 0.004 DBMET01153 0.046 0.004 DBMET01154 0.041 0.004 DBMET01155 0.023 0.007 DBMET01156 0.022 0.007 DBMET01157 | DBMET01152 | |
| 0.016 | 0.024 | 0.049 | Methylmalonyl-CoA mutase inhibitor | 0.042 0.001 DBMET01152 0.041 0.001 DBMET01153 0.049 0.001 DBMET01154 0.047 0.001 DBMET01155 0.039 0.001 DBMET01156 0.037 0.001 DBMET01157 | DBMET01154 | |
| 0.051 | 0.06 | 0.45 | Purinergic P2X1 antagonist | 0.354 0.001 DBMET01152 0.374 0.001 DBMET01153 0.428 0.001 DBMET01154 0.45 0.001 DBMET01155 0.351 0.001 DBMET01156 0.376 0.001 DBMET01157 | DBMET01155 | |
| 0.001 | 0.014 | 0.071 | Purinergic P2Y6 agonist | 0.025 0 DBMET01152 0.013 0.001 DBMET01153 0.055 0 DBMET01154 0.071 0 DBMET01155 0.039 0 DBMET01156 0.05 0 DBMET01157 | DBMET01155 | |
| 0.011 | 0.025 | 0.028 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.028 0.005 DBMET01152 0.027 0.005 DBMET01153 0.024 0.005 DBMET01154 0.023 0.006 DBMET01155 0.019 0.007 DBMET01156 0.018 0.007 DBMET01157 | DBMET01152 | |
| 0.01 | 0.025 | 0.029 | Adenosine A2b receptor agonist | 0.029 0.004 DBMET01152 0.026 0.004 DBMET01153 0.025 0.004 DBMET01154 0.025 0.004 DBMET01155 0.016 0.008 DBMET01156 0.016 0.008 DBMET01157 | DBMET01152 | |
| 0.016 | 0.033 | 0.343 | Purinergic P2X agonist | 0.163 0.002 DBMET01152 0.158 0.002 DBMET01153 0.289 0.001 DBMET01154 0.343 0.001 DBMET01155 0.214 0.001 DBMET01156 0.266 0.001 DBMET01157 | DBMET01155 | |
| 0.007 | 0.024 | 0.424 | Purinergic P2 agonist | 0.112 0.001 DBMET01152 0.101 0.001 DBMET01153 0.295 0.001 DBMET01154 0.424 0.001 DBMET01155 0.211 0.001 DBMET01156 0.277 0.001 DBMET01157 | DBMET01155 | |
| 0.007 | 0.024 | 0.424 | Purinergic receptor agonist | 0.112 0.001 DBMET01152 0.101 0.001 DBMET01153 0.295 0.001 DBMET01154 0.424 0.001 DBMET01155 0.211 0.001 DBMET01156 0.277 0.001 DBMET01157 | DBMET01155 | |
| 0.006 | 0.024 | 0.408 | Purinergic P2Y agonist | 0.103 0.001 DBMET01152 0.092 0.001 DBMET01153 0.273 0.001 DBMET01154 0.408 0.001 DBMET01155 0.19 0.001 DBMET01156 0.255 0.001 DBMET01157 | DBMET01155 | |
| 0.001 | 0.024 | 0.119 | Purinergic P2Y4 agonist | 0.015 0.001 DBMET01152 0.013 0.001 DBMET01153 0.06 0.001 DBMET01154 0.119 0 DBMET01155 0.038 0.001 DBMET01156 0.062 0.001 DBMET01157 | DBMET01155 | |
| 0.115 | 0.139 | 0.202 | Adenylate cyclase stimulant | 0.202 0.013 DBMET01152 0.187 0.02 DBMET01153 0.172 0.033 DBMET01154 0.163 0.044 DBMET01155 0.132 0.098 DBMET01156 0.122 0.121 DBMET01157 | DBMET01152 | |
| 0.042 | 0.069 | 0.297 | Purinergic P2X2 antagonist | 0.241 0.003 DBMET01152 0.24 0.003 DBMET01153 0.28 0.002 DBMET01154 0.297 0.002 DBMET01155 0.259 0.003 DBMET01156 0.276 0.002 DBMET01157 | DBMET01155 | |
| 0.013 | 0.042 | 0.155 | Adenosine A1 receptor agonist | 0.155 0.003 DBMET01152 0.125 0.003 DBMET01153 0.107 0.004 DBMET01154 0.099 0.004 DBMET01155 0.054 0.005 DBMET01156 0.052 0.005 DBMET01157 | DBMET01152 | |
| 0.101 | 0.136 | 0.138 | Cell wall synthesis inhibitor | 0.124 0.094 DBMET01152 0.138 0.077 DBMET01153 0.123 0.095 DBMET01154 | DBMET01153 | |
| 0.023 | 0.081 | 0.338 | Ribonucleotide reductase inhibitor | 0.201 0.007 DBMET01152 0.156 0.011 DBMET01153 0.27 0.005 DBMET01154 0.307 0.004 DBMET01155 0.312 0.004 DBMET01156 0.338 0.004 DBMET01157 | DBMET01157 | |
| 0.023 | 0.093 | 0.06 | Geranyltranstransferase inhibitor | 0.06 0.013 DBMET01154 0.054 0.019 DBMET01155 0.04 0.037 DBMET01156 | DBMET01154 | |
| 0.021 | 0.091 | 0.17 | Ribonucleoside-diphosphate reductase inhibitor | 0.15 0.011 DBMET01152 0.111 0.017 DBMET01153 0.162 0.01 DBMET01154 0.151 0.011 DBMET01155 0.17 0.009 DBMET01156 0.158 0.01 DBMET01157 | DBMET01156 | |
| 0.12 | 0.191 | 0.703 | Heat shock protein 70 antagonist | 0.384 0.003 DBMET01152 0.437 0.002 DBMET01153 0.657 0.002 DBMET01154 0.703 0.001 DBMET01155 0.337 0.003 DBMET01156 0.382 0.003 DBMET01157 | DBMET01155 | |
| 0.06 | 0.133 | 0.167 | Triose-phosphate isomerase inhibitor | 0.167 0.016 DBMET01152 0.125 0.03 DBMET01153 0.096 0.052 DBMET01154 0.087 0.064 DBMET01155 | DBMET01152 | |
| 0.023 | 0.099 | 0.315 | Nicotinic acid receptor 1 agonist | 0.308 0.003 DBMET01152 0.315 0.003 DBMET01153 0.27 0.003 DBMET01154 0.257 0.003 DBMET01155 0.258 0.003 DBMET01156 0.246 0.003 DBMET01157 | DBMET01153 | |
| 0.06 | 0.141 | 0.59 | UDP-glucose 4-epimerase inhibitor | 0.541 0.002 DBMET01152 0.514 0.002 DBMET01153 0.578 0.001 DBMET01154 0.59 0.001 DBMET01155 0.569 0.001 DBMET01156 0.581 0.001 DBMET01157 | DBMET01155 | |
| 0.033 | 0.117 | 0.357 | HIV-1 reverse transcriptase inhibitor | 0.139 0.016 DBMET01152 0.195 0.01 DBMET01153 0.29 0.005 DBMET01154 0.345 0.005 DBMET01155 0.305 0.005 DBMET01156 0.357 0.005 DBMET01157 | DBMET01157 | |
| 0.149 | 0.237 | 0.581 | Immunomodulator | 0.549 0.017 DBMET01152 0.467 0.028 DBMET01153 0.581 0.013 DBMET01154 0.562 0.015 DBMET01155 0.528 0.019 DBMET01156 0.506 0.022 DBMET01157 | DBMET01154 | |
| 0.038 | 0.137 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | 0.063 0.039 DBMET01154 0.07 0.028 DBMET01155 | DBMET01155 | |
| 0.017 | 0.12 | 0.086 | Guanylate cyclase inhibitor | 0.078 0.003 DBMET01152 0.076 0.004 DBMET01153 0.084 0.002 DBMET01154 0.086 0.002 DBMET01155 0.084 0.002 DBMET01156 0.086 0.002 DBMET01157 | DBMET01157 | |
| 0.026 | 0.142 | 0.063 | Glucose-6-phosphate isomerase inhibitor | 0.063 0.016 DBMET01152 0.055 0.023 DBMET01153 0.044 0.041 DBMET01154 | DBMET01152 | |
| 0.005 | 0.128 | 0.219 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.188 0.002 DBMET01152 0.141 0.002 DBMET01153 0.219 0.002 DBMET01154 0.184 0.002 DBMET01155 0.069 0.004 DBMET01156 0.056 0.004 DBMET01157 | DBMET01154 | |
| 0.024 | 0.155 | 0.068 | Carbonic anhydrase V inhibitor | 0.068 0.045 DBMET01152 | DBMET01152 | |
| 0.013 | 0.146 | 0.376 | Inosine monophosphate dehydrogenase inhibitor | 0.33 0.002 DBMET01152 0.246 0.003 DBMET01153 0.376 0.002 DBMET01154 0.319 0.002 DBMET01155 0.133 0.004 DBMET01156 0.113 0.005 DBMET01157 | DBMET01154 | |
| 0.056 | 0.219 | 0.106 | Hematopoietic | 0.106 0.03 DBMET01152 0.105 0.031 DBMET01153 0.085 0.059 DBMET01154 0.082 0.066 DBMET01155 0.084 0.063 DBMET01156 0.081 0.071 DBMET01157 | DBMET01152 | |
| 0.05 | 0.215 | 0.427 | Alkylator | 0.236 0.018 DBMET01152 0.427 0.006 DBMET01153 0.199 0.026 DBMET01154 0.172 0.036 DBMET01155 0.235 0.018 DBMET01156 0.205 0.025 DBMET01157 | DBMET01153 | |
| 0.01 | 0.178 | 0.518 | Purinergic P2Y antagonist | 0.412 0.002 DBMET01152 0.398 0.002 DBMET01153 0.488 0.002 DBMET01154 0.518 0.001 DBMET01155 0.45 0.002 DBMET01156 0.479 0.002 DBMET01157 | DBMET01155 | |
| 0.058 | 0.236 | 0.649 | Aldehyde dehydrogenase inhibitor | 0.487 0.004 DBMET01152 0.486 0.004 DBMET01153 0.649 0.003 DBMET01154 0.602 0.004 DBMET01155 0.31 0.011 DBMET01156 0.268 0.015 DBMET01157 | DBMET01154 | |
| 0.077 | 0.257 | 0.483 | DNA methylase inhibitor | 0.481 0.006 DBMET01152 0.483 0.006 DBMET01153 0.403 0.01 DBMET01154 0.36 0.015 DBMET01155 0.399 0.011 DBMET01156 0.357 0.016 DBMET01157 | DBMET01153 | |
| 0.006 | 0.192 | 0.153 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.115 0.002 DBMET01152 0.102 0.003 DBMET01153 0.153 0.002 DBMET01154 0.141 0.002 DBMET01155 0.087 0.003 DBMET01156 0.083 0.003 DBMET01157 | DBMET01154 | |
| 0.098 | 0.285 | 0.313 | DNA damaging | 0.247 0.082 DBMET01152 0.242 0.085 DBMET01154 0.197 0.118 DBMET01155 0.313 0.052 DBMET01156 0.26 0.075 DBMET01157 | DBMET01156 | |
| 0.044 | 0.25 | 0.108 | Thioredoxin inhibitor | 0.108 0.04 DBMET01156 0.102 0.046 DBMET01157 | DBMET01156 | |
| 0.037 | 0.262 | 0.596 | Aminoacyl-tRNA synthetase inhibitor | 0.418 0.004 DBMET01152 0.407 0.004 DBMET01153 0.546 0.003 DBMET01154 0.596 0.003 DBMET01155 0.477 0.003 DBMET01156 0.523 0.003 DBMET01157 | DBMET01155 | |
| 0.011 | 0.242 | 0.174 | RNA-directed RNA polymerase inhibitor | 0.046 0.014 DBMET01152 0.046 0.014 DBMET01153 0.134 0.004 DBMET01154 0.174 0.004 DBMET01155 0.094 0.005 DBMET01156 0.114 0.005 DBMET01157 | DBMET01155 | |
| 0.043 | 0.282 | 0.138 | Psychostimulant | 0.138 0.128 DBMET01153 | DBMET01153 | |
| 0.081 | 0.327 | 0.538 | Phospholipase C inhibitor | 0.538 0.005 DBMET01152 0.529 0.005 DBMET01153 0.295 0.019 DBMET01154 0.249 0.025 DBMET01155 0.178 0.062 DBMET01156 0.165 0.08 DBMET01157 | DBMET01152 | |
| 0.02 | 0.281 | 0.16 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.116 0.03 DBMET01152 0.089 0.044 DBMET01153 0.16 0.016 DBMET01154 0.144 0.021 DBMET01155 0.085 0.047 DBMET01156 0.073 0.058 DBMET01157 | DBMET01154 | |
| 0.004 | 0.264 | 0.051 | Uridine phosphorylase inhibitor | 0.051 0.008 DBMET01152 0.041 0.011 DBMET01153 | DBMET01152 | |
| 0.037 | 0.307 | 0.346 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.311 0.005 DBMET01152 0.261 0.009 DBMET01153 0.346 0.005 DBMET01154 0.311 0.005 DBMET01155 0.162 0.023 DBMET01156 0.139 0.03 DBMET01157 | DBMET01154 | |
| 0.032 | 0.309 | 0.097 | Anabolic | 0.09 0.078 DBMET01154 0.097 0.067 DBMET01155 | DBMET01155 | |
| 0.094 | 0.398 | 0.508 | Vasodilator, coronary | 0.35 0.055 DBMET01152 0.407 0.033 DBMET01153 0.479 0.019 DBMET01154 0.508 0.014 DBMET01155 0.286 0.1 DBMET01156 0.31 0.08 DBMET01157 | DBMET01155 | |
| 0.004 | 0.308 | 0.226 | HCV NS5B polymerase inhibitor | 0.055 0.009 DBMET01152 0.073 0.007 DBMET01153 0.165 0.004 DBMET01154 0.226 0.004 DBMET01155 0.088 0.005 DBMET01156 0.114 0.004 DBMET01157 | DBMET01155 | |
| 0.037 | 0.348 | 0.342 | Pyruvate kinase inhibitor | 0.181 0.093 DBMET01152 0.204 0.079 DBMET01153 0.298 0.048 DBMET01154 0.342 0.036 DBMET01155 | DBMET01155 | |
| 0.104 | 0.417 | 0.23 | Calcium channel activator | 0.23 0.171 DBMET01153 | DBMET01153 | |
| 0.045 | 0.36 | 0.115 | Mannose-6-phosphate isomerase inhibitor | 0.115 0.11 DBMET01152 | DBMET01152 | |
| 0.05 | 0.38 | 0.647 | Hexokinase inhibitor | 0.483 0.003 DBMET01152 0.426 0.004 DBMET01153 0.621 0.002 DBMET01154 0.647 0.002 DBMET01155 0.421 0.004 DBMET01156 0.449 0.004 DBMET01157 | DBMET01155 | |
| 0.025 | 0.359 | 0.18 | Mucolytic | 0.101 0.076 DBMET01152 0.148 0.033 DBMET01153 0.165 0.024 DBMET01154 0.18 0.019 DBMET01155 0.101 0.075 DBMET01156 0.113 0.061 DBMET01157 | DBMET01155 | |
| 0.038 | 0.373 | 0.179 | Acetylcholine M1 receptor antagonist | 0.163 0.064 DBMET01154 0.179 0.052 DBMET01155 0.136 0.088 DBMET01156 0.151 0.074 DBMET01157 | DBMET01155 | |
| 0.005 | 0.346 | 0.274 | Phosphorylase inhibitor | 0.186 0.005 DBMET01152 0.136 0.008 DBMET01153 0.256 0.004 DBMET01154 0.274 0.004 DBMET01155 0.164 0.006 DBMET01156 0.183 0.005 DBMET01157 | DBMET01155 | |
| 0.015 | 0.359 | 0.271 | Purinergic P2X4 antagonist | 0.119 0.004 DBMET01152 0.11 0.004 DBMET01153 0.225 0.003 DBMET01154 0.271 0.003 DBMET01155 0.078 0.007 DBMET01156 0.091 0.005 DBMET01157 | DBMET01155 | |
| 0.047 | 0.415 | 0.172 | Transcription factor STAT6 inhibitor | 0.156 0.019 DBMET01152 0.172 0.012 DBMET01153 0.117 0.065 DBMET01154 0.105 0.093 DBMET01155 | DBMET01153 | |
| 0.077 | 0.447 | 0.659 | Vasodilator, peripheral | 0.407 0.053 DBMET01152 0.407 0.053 DBMET01153 0.629 0.013 DBMET01154 0.659 0.009 DBMET01155 0.449 0.041 DBMET01156 0.491 0.03 DBMET01157 | DBMET01155 | |
| 0.016 | 0.387 | 0.271 | Expectorant | 0.139 0.04 DBMET01152 0.223 0.016 DBMET01153 0.244 0.013 DBMET01154 0.271 0.01 DBMET01155 0.137 0.041 DBMET01156 0.157 0.033 DBMET01157 | DBMET01155 | |
| 0.117 | 0.496 | 0.495 | Caspase 9 stimulant | 0.495 0.062 DBMET01152 0.421 0.099 DBMET01153 0.292 0.202 DBMET01154 0.255 0.247 DBMET01155 | DBMET01152 | |
| 0.02 | 0.413 | 0.11 | Antiviral (Hepatitis D) | 0.096 0.005 DBMET01154 0.11 0.004 DBMET01155 0.094 0.005 DBMET01156 0.108 0.004 DBMET01157 | DBMET01155 | |
| 0.029 | 0.44 | 0.111 | Protein kinase stimulant | 0.111 0.103 DBMET01152 | DBMET01152 | |
| 0.012 | 0.462 | 0.043 | Antibiotic Aminoglycoside-like | 0.042 0.019 DBMET01152 0.043 0.018 DBMET01153 0.039 0.022 DBMET01154 0.039 0.022 DBMET01155 0.041 0.02 DBMET01156 0.04 0.021 DBMET01157 | DBMET01153 | |
| 0.004 | 0.537 | 0.254 | Purinergic P2Y12 antagonist | 0.086 0.004 DBMET01152 0.085 0.004 DBMET01153 0.201 0.004 DBMET01154 0.254 0.003 DBMET01155 0.1 0.004 DBMET01156 0.146 0.004 DBMET01157 | DBMET01155 | |
| 0.034 | 0.605 | 0.334 | Antithrombotic | 0.281 0.102 DBMET01152 0.334 0.07 DBMET01153 0.237 0.137 DBMET01154 0.204 0.172 DBMET01155 | DBMET01153 | |
| 0.019 | 0.622 | 0.156 | Platelet aggregation inhibitor | 0.156 0.122 DBMET01153 | DBMET01153 | |
| 0.003 | 0.675 | 0.114 | Purinergic P2Y1 antagonist | 0.087 0.003 DBMET01152 0.086 0.003 DBMET01153 0.096 0.003 DBMET01154 0.107 0.003 DBMET01155 0.101 0.003 DBMET01156 0.114 0.002 DBMET01157 | DBMET01157 | |
| 0.014 | 0.687 | 0.158 | Angiogenesis stimulant | 0.157 0.118 DBMET01152 0.158 0.117 DBMET01153 | DBMET01153 | |
| 0.01 | 0.811 | 0.196 | Insulin secretagoues | 0.13 0.096 DBMET01152 0.119 0.113 DBMET01153 0.184 0.045 DBMET01154 0.196 0.038 DBMET01155 0.129 0.098 DBMET01157 | DBMET01155 | |
| 0.004 | 0.812 | 0.303 | Purinergic P2 antagonist | 0.18 0.008 DBMET01152 0.153 0.01 DBMET01153 0.269 0.005 DBMET01154 0.303 0.005 DBMET01155 0.238 0.005 DBMET01156 0.272 0.005 DBMET01157 | DBMET01155 | |
| 0.053 | 0.883 | 0.271 | Peptidyltransferase inhibitor | 0.241 0.057 DBMET01152 0.271 0.037 DBMET01153 0.221 0.075 DBMET01154 0.215 0.081 DBMET01155 0.255 0.047 DBMET01156 0.249 0.052 DBMET01157 | DBMET01153 | |
| 0.009 | 0.895 | 0.294 | Apoptosis agonist | 0.294 0.177 DBMET01152 | DBMET01152 | |
| 0.003 | 0.891 | 0.04 | Purinergic P2X3 antagonist | 0.033 0.026 DBMET01154 0.04 0.017 DBMET01155 | DBMET01155 | |
| 0.029 | 0.936 | 0.126 | Sphingosine 1-phosphate receptor 2 agonist | 0.126 0.047 DBMET01152 0.113 0.068 DBMET01153 | DBMET01152 | |
| 0.003 | 0.912 | 0.032 | Growth factor receptor-bound protein 2 antagonist | 0.032 0.031 DBMET01152 | DBMET01152 | |
| 0.005 | 0.92 | 0.267 | Vasodilator | 0.197 0.107 DBMET01152 0.225 0.086 DBMET01153 0.248 0.07 DBMET01154 0.267 0.061 DBMET01155 0.166 0.135 DBMET01156 0.187 0.116 DBMET01157 | DBMET01155 | |
| 0.004 | 0.929 | 0.069 | Protein 50S ribosomal subunit inhibitor | 0.063 0.028 DBMET01152 0.069 0.024 DBMET01153 0.057 0.033 DBMET01154 0.055 0.035 DBMET01155 | DBMET01153 | |
| 0.012 | 0.945 | 0.197 | Apoptosis antagonist | 0.197 0.183 DBMET01152 | DBMET01152 | |
| 0.004 | 0.951 | 0.046 | Cyclophilin A inhibitor | 0.046 0.008 DBMET01153 | DBMET01153 | |
| 0.002 | 0.952 | 0.301 | Purinergic P2T antagonist | 0.093 0.005 DBMET01152 0.096 0.005 DBMET01153 0.226 0.004 DBMET01154 0.301 0.003 DBMET01155 0.13 0.004 DBMET01156 0.163 0.004 DBMET01157 | DBMET01155 | |
| 0.01 | 0.993 | 0.151 | Transcription factor NF kappa B stimulant | 0.117 0.027 DBMET01152 0.126 0.022 DBMET01153 0.151 0.016 DBMET01154 0.145 0.017 DBMET01155 0.122 0.024 DBMET01156 0.118 0.026 DBMET01157 | DBMET01154 | |
| 0.006 | 0.992 | 0.099 | Toll-Like receptor 4 antagonist | 0.099 0.071 DBMET01152 | DBMET01152 | |
| 0.004 | 0.992 | 0.189 | Platelet antagonist | 0.174 0.122 DBMET01154 0.189 0.11 DBMET01155 | DBMET01155 | |
| 0.003 | 0.995 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 DBMET01152 0.035 0.007 DBMET01153 0.03 0.012 DBMET01154 0.029 0.013 DBMET01155 0.028 0.014 DBMET01156 0.028 0.015 DBMET01157 | DBMET01153 | |
| 0.003 | 0.997 | 0.063 | Adenine nucleotide translocase inhibitor | 0.062 0.025 DBMET01152 0.063 0.023 DBMET01153 0.057 0.034 DBMET01154 0.056 0.038 DBMET01155 | DBMET01153 | |
| 0.001 | 0.996 | 0.047 | Sphingosine 1-phosphate receptor 3 agonist | 0.047 0.018 DBMET01152 0.045 0.019 DBMET01153 | DBMET01152 | |
| 0 | 1 | 0.013 | Mannitol 2-dehydrogenase inhibitor | 0.013 0.003 DBMET01152 0.012 0.004 DBMET01153 | DBMET01152 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |